A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera Delayed-Release Capsules on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (REALIZE)
Phase of Trial: Phase IV
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- Acronyms REALIZE
- Sponsors Biogen
- 10 Jun 2017 Biomarkers information updated
- 28 Apr 2017 Results of post-hoc analysis (n= 476), presented at the 69th Annual Meeting of the American Academy of Neurology.
- 25 Aug 2016 Status changed to completed.